Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance

A Shapira, YD Livney, HJ Broxterman… - Drug resistance updates, 2011 - Elsevier
Anticancer drug resistance almost invariably emerges and poses major obstacles towards
curative therapy of various human malignancies. In the current review we will distinguish …
被引用次数：567 相关文章

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance

A Shapira, YD Livney… - … in antimicrobial and …, 2011 - pubmed.ncbi.nlm.nih.gov
Anticancer drug resistance almost invariably emerges and poses major obstacles towards
curative therapy of various human malignancies. In the current review we will distinguish …

Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

A Shapira, YD Livney, HJ Broxterman… - … Updates: Reviews and …, 2011 - europepmc.org
Anticancer drug resistance almost invariably emerges and poses major obstacles towards
curative therapy of various human malignancies. In the current review we will distinguish …

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

A Shapira, YD Livney, HJ Broxterman… - Drug Resistance …, 2011 - infona.pl
Anticancer drug resistance almost invariably emerges and poses major obstacles towards
curative therapy of various human malignancies. In the current review we will distinguish …
[PDF] academia.edu

[PDF][PDF] Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

A Shapira, YD Livney, HJ Broxterman… - Drug Resistance …, 2011 - academia.edu
abstract Anticancer drug resistance almost invariably emerges and poses major obstacles
towards curative therapy of various human malignancies. In the current review we will …